Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 1 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 1 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 1 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 1 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.3387 | 0.5 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.3387 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.3387 | 0.3387 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 1 | 0.5 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0023 | 0.3387 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0023 | 0.3387 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.3387 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 1 | 0.5 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.3387 | 0.5 |
Echinococcus granulosus | dna polymerase kappa | 0.0023 | 0.3387 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.3387 | 0.3387 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 1 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.3387 | 0.5 |
Echinococcus multilocularis | dna polymerase kappa | 0.0023 | 0.3387 | 0.5 |
Schistosoma mansoni | DNA polymerase eta | 0.0023 | 0.3387 | 0.5 |
Echinococcus multilocularis | dna polymerase eta | 0.0023 | 0.3387 | 0.5 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.3387 | 0.5 |
Echinococcus granulosus | dna polymerase eta | 0.0023 | 0.3387 | 0.5 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0023 | 0.3387 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.3387 | 0.5 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.3387 | 0.5 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.3387 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 7.9433 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 125.8925 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.